RecruitingNot ApplicableNCT05767216

Genetic and Epigenetic Variations in Heterokaryotypic Monozygotic Twins Discordant for Down Syndrome


Sponsor

Institut Jerome Lejeune

Enrollment

5 participants

Start Date

Dec 20, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Heterokaryotypic monozygotic twins discordant for Down syndrome (DS) are very rare, with an incidence estimated to be less than 1 over 7,000,000 pregnancy in the general population. Sharing the same genetic patrimony, except for an additional chromosome 21 for one of them, any gene-expression difference between them could be attributed only to the supernumerary chromosome 21 and not to polymorphic variability in the rest of the genome. The setting up of a prospective longitudinal study will offer the major advantage of allowing genetic and epigenetic comparisons between them and to obtain important information on the impact of the environment in which they live and grow up.


Eligibility

Sex: MALEMin Age: 4 YearsMax Age: 11 Years

Inclusion Criteria6

  • Twins of a heterokaryotypic monozygotic pair discordant for DS
  • Twins of a sex- and class of age-matched dizygotic pair discordant for DS,
  • Sex- and class of age-matched patient with mosaic T21
  • Subject's parents/legal representatives willing to give written informed consent.
  • Subject and his/her parents/legal representatives must be able/willing to comply with the protocol.
  • Subject covered by social welfare.

Exclusion Criteria1

  • None

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBiological sampling

Blood, skin and stool samples for laboratory analysis


Locations(1)

Institut Jérôme Lejeune

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05767216


Related Trials